7-OH Dosage Guide for Research: Starting Points, Titration, and What the Literature Says
Research · 9 min · 2026-04-18
Researchers working with isolated 7-hydroxymitragynine need a starting dose framework. This guide pulls from current literature and real-world manufacturer specifications to lay out typical research-context dose ranges.
# 7-OH Dosage Guide for Research: Starting Points, Titration, and What the Literature Says
Dose precision is the main reason isolated 7-OH tablets exist — you can replicate a study design with standardized units in a way that [whole leaf](/blog/7oh-extract-vs-leaf) cannot match. This guide covers starting doses, titration approaches, and literature benchmarks for researchers.
## Typical Research Starting Dose
Most published research on isolated 7-OH uses starting doses in the 1-5 mg range. At 7OH North our [standard tablets](/product/pure-7oh-labs-blue-raz) are scored for 5 mg increments, which aligns with the conservative end of research protocols.
## Factors That Shift the Starting Dose
Body mass, previous exposure to opioid-adjacent compounds, research question (acute vs steady-state), and whether the subject is naive or experienced all shift the starting dose. Research-naive protocols typically start at the lowest available tablet increment.
## Titration Pattern
Standard titration in research protocols:
- Day 1-3: starting dose (5 mg), observation and record
- Day 4-7: if no adverse observations, 10 mg
- Day 8+: increment by 5 mg every 3-5 days as the protocol requires
Record everything: time of dose, food status, concurrent compounds, observed effects, duration. Dose-response curves require clean data.
## Maximum Documented Doses
Published research varies. Isolated 7-OH at 20-30 mg per dose is well-documented in the literature. Above 30 mg per dose is less common and carries diminishing marginal returns in most studies.
## Frequency Considerations
Single-dose studies: straightforward. Multi-dose studies require attention to tolerance development. [7-OH](/blog/7oh-vs-mitragynine) shows tolerance effects similar to other mu-opioid partial agonists on repeat exposure; research protocols should design appropriate washout periods.
## Format and Dose
[Tablets](/shop) are most common in research because of dose precision. [Kratom shots](/product/bare-kratom-shots-blue-razz) are used for studies where onset speed matters — see [tablets vs shots](/blog/kratom-tablets-vs-shots). [Whole leaf](/blog/kratom-tablets-vs-powder) is used only when full alkaloid spectrum is the research question.
## Lab Testing and Dose Accuracy
Your dose is only as accurate as the vendor's testing. A tablet labelled 5 mg that actually contains 3.2 mg of active ingredient invalidates any dose-response analysis. Third-party COAs are the non-negotiable control — see [why lab testing matters](/blog/importance-of-lab-testing) and [our lab results](/lab-results).
## Record Keeping Template
A usable research log for each administration:
- Date and time
- Dose (mg) and format
- Product batch / lot number
- Food status (fasted / fed / specific meal)
- Concurrent compounds or conditions
- Observation start time, duration, description
- Adverse events
## Getting Started
Order from a Canadian supplier with published COAs. Start at the lowest available dose. Keep records from the first administration. Titrate conservatively. Browse [our catalogue](/shop) or read [our beginner's guide](/blog/beginners-7oh-guide) for a softer intro.
*Products are sold for research purposes. Not for human consumption.*